Loading clinical trials...
Loading clinical trials...
This study was intended to evaluate the efficacy, safety and tolerability of atacicept compared to placebo and to explore the neuroprotective effect of atacicept as assessed by OCT in subjects with ON...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
EMD Serono
Collaborators
NCT07100990 · Optic Neuritis, Myelitis, and more
NCT06453694 · Optic Neuritis
NCT03401879 · Multiple Sclerosis, Relapsing-Remitting, Optic Neuritis
NCT06776224 · Multiple Sclerosis, Optic Neuritis, Demyelinating Disease
NCT06389968 · Multiple Sclerosis, Relapsing-Remitting, Optic Neuritis
Research Site
Birmingham, Alabama
Research Site
Aurora, Colorado
Research Site
Fairfield, Connecticut
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions